Skip to main content
SpringerLink
Log in

Abiraterone acetate/prednisone

Hyperaldosteronism, hypokalaemia and lack of efficacy: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • de Almeida DCB, et al. Ascending Flaccid Paralysis Secondary to Hypokalemia in A Cancer Patient using Abiraterone-A Case Report. Current Drug Safety 18: 107-111, No. 1, 2023. Available from: URL: http://doi.org/10.2174/1574886317666220425140053 [Summarised from an abstract]

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abiraterone acetate/prednisone. Reactions Weekly 1942, 14 (2023). https://doi.org/10.1007/s40278-023-32623-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-32623-6

Search

Navigation